Results 11 to 20 of about 1,270,000 (363)

Improving Medication Regimen Recommendation for Parkinson’s Disease Using Sensor Technology

Sensors, 2021
Parkinson’s disease medication treatment planning is generally based on subjective data obtained through clinical, physician-patient interactions. The Personal KinetiGraph™ (PKG) and similar wearable sensors have shown promise in enabling objective ...
Jeremy Watts, Anahita Khojandi, Rama Vasudevan, Fatta B. Nahab, Ritesh A. Ramdhani   +4 more
doaj   +1 more source

Idelalisib and Rituximab Regimen [PDF]

Hospital Pharmacy, 2017
The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.
A. Kacee Barnett, Dominic A. Solimando, J. Aubrey Waddell   +2 more
openaire   +3 more sources

A regimen with caplacizumab, immunosuppression and plasma exchange prevents unfavorable outcomes in immune-mediated TTP.

Blood, 2020
The anti-von Willebrand factor nanobody caplacizumab was licensed for adults with immune-mediated thrombotic thrombocytopenic purpura (iTTP) based on prospective controlled trials. However, few data are available on post-marketing surveillance.
P. Coppo, M. Bubenheim, É. Azoulay, L. Galicier, Sandrine Malot, N. Bigé, P. Poullin, F. Provôt, Nihal Martis, C. Presne, O. Moranne, R. Benainous, A. Dossier, A. Séguin, M. Hié, A. Wynckel, Yahsou Delmas, J. Augusto, P. Pérez, V. Rieu, C. Barbet, F. Lhôte, M. Ulrich, A. Rumpler, S. de Witte, T. Krummel, A. Veyradier, Y. Benhamou   +27 more
semanticscholar   +1 more source

Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia

Journal of Clinical Oncology, 2020
PURPOSE Reduced-intensity conditioning (RIC) regimens have extended the curative potential of allogeneic stem-cell transplantation to older adults with high-risk acute myeloid leukemia (AML) and myelodysplasia (MDS) but are associated with a high risk of
C. Craddock, Aimee E Jackson, J. Loke, S. Siddique, A. Hodgkinson, J. Mason, Georgia Andrew, S. Nagra, R. Malladi, A. Peniket, M. Gilleece, R. Salim, E. Tholouli, V. Potter, C. Crawley, K. Wheatley, R. Protheroe, P. Vyas, A. Hunter, A. Parker, K. WIlson, J. Pavlů, J. Byrne, R. Dillon, N. Khan, N. McCarthy, S. Freeman   +26 more
semanticscholar   +1 more source

Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: A post-marketing, parallel control clinical trial

Human Vaccines & Immunotherapeutics, 2021
To compare the safety and immunogenicity of lyophilized PVRV under Zagreb and Essen regimen. A post-marketing parallel control clinical trial was conducted.
Lei Zhang, Shichun Huang, Li Cai, Zhenggang Zhu, Jian Chen, Sha Lu, Zerong Zhu, Man Zhang, Yuan Fang, Quan Hu   +9 more
doaj   +1 more source

Effect of Phone Text Message Reminders on Compliance with Rabies Post-Exposure Prophylaxis following Dog Bites in Rural Kenya

Vaccines, 2023
The prompt administration of post-exposure prophylaxis (PEP) is one of the key strategies for ending human deaths from rabies. A delay in seeking the first dose of rabies PEP, or failure to complete the recommended dosage, may result in clinical rabies ...
Veronicah M. Chuchu, Nyamai Mutono, Philet Bichanga, Philip M. Kitala, Daniel Ksee, Mathew Muturi, Athman Mwatondo, Carolyne Nasimiyu, Lawrence Akunga, Amine Amiche, Katie Hampson, Samuel M. Thumbi   +11 more
doaj   +1 more source

A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403.

Blood, 2019
Retrospective studies have suggested that older adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) have better survival rates when treated using a pediatric ALL regimen administered by pediatric treatment teams.
W. Stock, S. Luger, A. Advani, Jun Yin, R. Harvey, C. Mullighan, C. Willman, N. Fulton, K. Laumann, G. Malnassy, E. Paietta, E. Parker, S. Geyer, K. Mrózek, C. Bloomfield, B. Sanford, G. Marcucci, M. Liedtke, D. Claxton, M. Foster, J. Bogart, J. Grecula, F. Appelbaum, H. Erba, M. Litzow, M. Tallman, R. Stone, R. Larson   +27 more
semanticscholar   +1 more source

Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report

Clinical Case Reports, 2023
Philadelphia chromosome‐positive acute myeloid leukemia (Ph + AML) is a rare type of AML with a low survival rate and poor prognosis. We first report a Ph + AML patient who remained in long‐term remission after the combination of flumatinib and ...
Si‐Man Huang, Tao Tao, Chao‐Ling Wan, Tian‐Mei Wu, Han‐Yu Cao, Yan Qiu, Xiang‐Dong Shen, Bin‐Ru Wang, Shuai‐Shuai Ge, Yan‐Yan Li, Tong‐Tong Zhang, Bing Wu, Sheng‐Li Xue   +12 more
doaj   +1 more source

Efficacy and safety of Venetoclax-based regimens in relapsed or refractory multiple myeloma: a systematic review and meta-analysis of prospective clinical trials

Annals of Medicine, 2023
Background Multiple myeloma (MM) is an incurable malignancy. Venetoclax (VEN) shows a meaningful effect in MM patients who are relapsed or refractory (RR) to previous standard therapies.Objective This study aimed to assess the efficacy and safety of VEN ...
Wei He, Fang He, Huixian Hu
doaj   +1 more source

CHANGES IN THE TREATMENT PLANS OF GLAUCOMA PATIENTS IN A REAL-WORLD SITUATION

Khyber Medical University Journal, 2022
OBJECTIVE: To determine the changes in glaucoma prescriptions during a single visit in real-world situation at Al-Shifa Trust Eye Hospital, Rawalpindi, Pakistan.
Muhammad Sadiq, Yousaf Jamal Mahsood, Waqar Ahmad, Mir Azam Khan, Farah Akhtar   +4 more
doaj   +1 more source